Skip to main content
Toggle navigation
Search
Home
Preview Program
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
A
136
A Case of Tianeptine Overdose Requiring ICU Admission
Favorite
9
A Drug Identification Program as a Harm Reduction Initiative
Favorite
34
A Longitudinal Analysis of PrEP Eligibility Among Women who Inject Drugs
Favorite
63
Addressing Gaps in Buprenorphine Treatment Among Black and Non-English-Speaking Patients
Favorite
103
Adolescent and Caregiver Perspective on Substance Use Screening in the Emergency Department
Favorite
102
Adolescent-Specific Risk and Protective Factors of Substance Use Among High School Students
Favorite
120
Advancing Alcohol Use Disorder Treatment Through Clinician Training Program
Favorite
21
Advancing the Evidence on Emergency Department and Hospital Linkage to Methadone Treatment
Favorite
45
Age, Symptom Management, and Cannabis Use Disorder Risk: A Cross-Sectional Study
Favorite
85
Alcohol Use Disorder Medication Initiation During Alcohol Withdrawal Hospitalizations
Favorite
74
An OUD Support Line Improves Opioid Use Disorder Treatment in Hospitalized Patients
Favorite
58
Assessing Readability and Stigma of ChatGPT’s Opioid Use Disorder FAQs
Favorite
17
Attitudes of Patients Who Use Drugs Towards Policies Regarding In-Hospital Use
Favorite
82
Augmented Reality Technology Engages Opioid Use Disorder Patients in Their Treatment
Favorite
B
52
Barriers to Healthcare Utilization and Adolescent Prescription Drug Misuse During COVID-19
Favorite
18
Barriers to Prescribing Varenicline and NRT in Inpatient Psychiatric Settings
Favorite
98
Breaking Barriers: Advancing Addiction Care for Young Immigrant Adults
Favorite
35
Breaking Barriers: Social Vulnerability and Retention among Pregnant Women with Opioid Use
Favorite
69
Breaking the Cycle: Life Saving ICD in Methadone-Induced Torsades de Pointes
Favorite
132
Breaking the Cycle: GLP-1/GIP Agonist Treatment and Alcohol Use Disorder
Favorite
56
Bromazolam Withdrawal Requiring ICU Admission: Case Report of Designer Benzodiazepine Use
Favorite
62
Buprenorphine for Naltrexone-XR-Precipitated Opioid Withdrawal
Favorite
126
Buprenorphine Rescue for XR Naltrexone-Precipitated Opioid Withdrawal: A Case Report
Favorite
C
105
Characteristics Associated with Overdose after Opioid Prescription to Younger Individuals
Favorite
25
Clinical Characteristics Differences Between Sexual Minorities and Heterosexuals with OUD
Favorite
80
Comparative Outcomes of Opioid Withdrawal Management for Patients Admitted with Bacteremia
Favorite
30
Coping with Crisis: Housing Instability, Food Insecurity, and Cannabis Use in Pregnancy
Favorite
D
81
Deep Learning-Based Detection of Xylazine Exposure from Wound Imaging
Favorite
54
Determinants of Increased Travel Burden for Patients Treated with Buprenorphine
Favorite
15
Discharge on MOUD Reduces Relapse in Trauma Patients with Prior Opioid Dependence
Favorite
133
Disulfiram: An Effective Yet Underutilized Drug for AUD
Favorite
83
Drug Supply Monitoring: Feedback from People Who Use Drugs
Favorite
E
51
Elevating Patient Voices: Substance Use Care, Recovery Support, & Overdose Prevention
Favorite
29
Emergence of Local Anesthetics in the Los Angeles Illicit Fentanyl Supply
Favorite
20
Emergency Department Utilization for OUD Before and After Receiving Buprenorphine from EMS
Favorite
86
Enhancing Viral Hepatitis Harm Reduction through a Comprehensive Addiction Consult Service
Favorite
50
Evaluating Adolescent Medicine Providers’ Barriers to SUD Screening and Intervention
Favorite
119
Evaluation of a Family Medicine Contingency Management Program for Substance Use Disorder
Favorite
110
Expanding Community-Led Partnerships: Residency Integration in a Harm Reduction Clinic
Favorite
10
Exploring Street Medicine's Acceptability: A Qualitative Study of Team Member Perspectives
Favorite
F
76
Facilitators to Patients with Substance Use Disorders Seeking Care in the ED
Favorite
26
Factors Associated with Drug Harm Reduction Among Electronic Dance Music Event Attendees
Favorite
40
Family History Density: Impact on Participant Substance Use Onset and Duration
Favorite
H
11
Harm Reduction Vending Machines Increase Equitable Access to Naloxone and Health Supplies
Favorite
123
Heart Transplant Outcomes in Substance Use Disorder: A Nationwide Cohort Study
Favorite
31
Hepatitis C Virus Care Linkage for Peripartum Individuals with Opioid Use Disorder
Favorite
91
High Risk and Underserved: Drug and Sexual Patterns Among Women Who Inject
Favorite
I
57
Impact of Gabapentin Regulation on Opioid Overdose Trends, 2013-2022
Favorite
37
Impact of Integrated Substance Use and Obstetric Care on Delivery Outcomes
Favorite
19
Impact of Mental Health Conditions and Psychiatric Prescriptions on MOUD at Discharge
Favorite
13
Implementation Determinants of Harm Reduction Integration in Outpatient Clinical Settings
Favorite
12
Implementing an Opioid Overdose Prevention Program within a Community Mental Health Clinic
Favorite
109
Implementing Revised Methadone Treatment Regulations at NYS Opioid Treatment Programs
Favorite
130
Importance of Collaborative Care for Adolescents with OUD: A Case Report
Favorite
68
Improving Lives, Saving Money: Housing Solutions for Substance Use Disorders
Favorite
27
Improving Methadone Access: Creating a Reliable Methadone Clinic Database in Los Angeles
Favorite
127
Initiating Extended-Release Injectable Buprenorphine in Primary Care without a Test Dose
Favorite
43
Innovative Interprofessional Education Model for Substance Use Disorder Care
Favorite
79
Inpatient OUD Management: Associations with PDD, Readmission, and Mortality
Favorite
108
Instruments Assessing Long-Term Opioid Therapy for Chronic Pain: A Scoping Review
Favorite
92
Intimate Partner Violence Support in Perinatal Substance Use: Patient and Provider Insights
Favorite
K
65
Kratom and Kava Use Disorder & Withdrawal Management: A Case Study
Favorite
L
3
Leveraging Asian American & Pacific Islander Resilience in Substance Use Recovery
Favorite
134
Long-Acting Injectable Buprenorphine: A Vein-Saving Victory in Pediatric Case
Favorite
60
Low-Dose Dexmedetomidine: Repurposing an Intravenous Agent for Opioid & Alpha 2 Withdrawal
Favorite
M
42
Machine Learning to Assess Stimulant Therapy Risk for Stimulant Use Disorder
Favorite
101
Marijuana Exposures and Poisonings of Children Aged 12 and Under
Favorite
32
Maternal Attachment Moderates Effects of Substance Use on White-Matter Microstructure
Favorite
104
Medication Assisted Recovery Anonymous vs 12 Step Groups: Comparing MOUD Stigma Experiences
Favorite
84
Meta-analysis of the Therapeutic Role of TMS and tDCS in Opioid Disorder
Favorite
78
Methadone Dose and Patient-Directed Discharge in Persons with Prior Methadone Enrollment
Favorite
4
MOUD Treatment Receipt and Retention by Sociodemographics at a Safety-Net Health-System
Favorite
N
106
Naloxone and Medication for Opioid Use Disorder in US Emergency Departments
Favorite
36
National Estimates of Alcohol Use Disorder Diagnosis and Treatment in Pregnancy, 2006-2019
Favorite
23
Needle-Free Lidocaine Administration Before XR-BUP Decreases Patient Perceived Pain Score
Favorite
47
Neuromodulation in Transitional Age Youth Substance Use Disorders: A Narrative Review
Favorite
128
No, No Nootropics! A Case of Tianeptine and Phenibut Withdrawal/Use Disorder
Favorite
135
Not Just Fentanyl: Protracted Withdrawal from Para-Fluorofentanyl
Favorite
O
44
Opioid Use Disorder Medication Accessibility in Central and Outlying Texas Counties
Favorite
61
Opioid Withdrawal and Autonomic Complications Associated with Medetomidine Adulteration
Favorite
75
Optimizing Telephone Call Reminders to Improve Appointment Attendance at Outpatient Clinic
Favorite
P
77
Patient Factors Associated with Hospital Discharge on Buprenorphine Versus Methadone
Favorite
111
People Can Recover: Qualitative Findings from a Statewide Naloxone Distribution Project
Favorite
48
Perceived Need for Treatment Among Adults With Severe Substance Use Disorder
Favorite
93
Perceptions of Fertility among Treatment-Seeking Women with Opioid Use Disorder
Favorite
95
Perinatal Opioid Use Disorder Program in the Heart of the Opioid Epidemic
Favorite
33
Perinatal Quality Collaboratives: Supporting People with Substance Use Disorders
Favorite
107
Perioperative Buprenorphine Use Protects Against Long-Term Opioid Use
Favorite
96
Perspectives of Pregnant and Postpartum Persons on Xylazine Education and Home Testing
Favorite
53
Pharmacy Barriers to Receiving Buprenorphine Addiction Treatment Through Telehealth
Favorite
14
Physician Perspectives on Initiating Treatment of Hepatitis C during Hospitalization
Favorite
64
Polymicrobial Bacteremia from Licking Syringe Plungers: A Case Report and Scoping Review
Favorite
121
Predictors of Retention During and After Residential Treatment for Substance Use Disorders
Favorite
88
Prevalence and Correlates of AUD Diagnoses among Users of HIV Pre-Exposure Prophylaxis
Favorite
24
Prevalence of ADHD in Adults Seeking Methadone Treatment for Opioid Use Disorder
Favorite
122
Prevalent Comorbidities Associated with Substance Use Disorder in East Texas (2021-2024)
Favorite
59
Protracted Benzodiazepine Withdrawal in a Psychiatric Patient with Polysubstance Use
Favorite
46
Provider Experiences of SUD Management in Pediatric Hospitals: A Qualitative Study
Favorite
124
Psychogenic Non-Epileptic Seizures (PNES) in a Case of Alcohol Withdrawal Syndrome
Favorite
Q
28
Quetiapine, A Novel Additive to the Illicit Heroin Supply in Los Angeles
Favorite
R
2
Race and Insurance Influence on Medications for Opioid Use Disorder
Favorite
71
Race, Ethnicity & Language Differences in Medications for Alcohol Use Disorder Prescribing
Favorite
72
Racial Differences in LGBTQ+ Substance Use: Insights from All of Us Data
Favorite
73
Racial Disparities in Mental Health and Substance Use during the COVID-19 Pandemic
Favorite
1
Racial Disparities in Urine Toxicology Screening for Labor and Delivery Admissions
Favorite
129
Rapid Outpatient Initiation of Long-Acting Injectable Buprenorphine: A Case Series
Favorite
66
Recognizing Nitrous Oxide Toxicity: Key Neuropsychiatric Symptoms and Diagnostic Clues
Favorite
16
Recovery Capital among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder
Favorite
49
Reimagining SBIRT: Provider, Adolescent, and Caregiver Perceptions in Primary Care
Favorite
112
Retrospective Analysis of Buprenorphine Initiation in an Urban Street Medicine Program
Favorite
89
Risk Factors of Severe Maternal Morbidity in Individuals with Methamphetamine Use
Favorite
113
Rock Bottom Is Not a Motivator: From Opioid Addiction to Human Flourishing
Favorite
S
6
Scaling Up Low Barrier Wound Care for People who Use Drugs
Favorite
22
Secondary Outcomes from the START RCT to Improve OUD Care for Inpatients
Favorite
131
Self-Directed Ketamine Therapy and Withdrawal Syndrome: A Case Report
Favorite
39
Self-Harm as a Contributor to the “Fourth Wave”: Suicidality in Stimulant Overdoses
Favorite
41
Semaglutide as a Potential Breakthrough in Treatment of Alcohol Use Disorder
Favorite
87
Sex, Socioeconomic Status, and Self-Perceived Risk of Opioid Overdose
Favorite
114
Stigmatizing Language in the Medical Record After Addiction Consult Service Implementation
Favorite
5
Substance Treatment Phone Line Expansion Improves Connection to Treatment and Resources
Favorite
115
Substance Use Disorder Patient Experience with “Leave Behind Naloxone” in the Community
Favorite
67
Sustained Positive Buprenorphine after LAIs and Naltrexone Micro-Dosing in Treating OUD
Favorite
T
99
The Kids are Not Alright: Missed Opportunities for Inpatient Adolescent Nicotine Screening
Favorite
118
The UCSF SBIRT Collaborative Care Program for SUD: Design, Development, and Implementation
Favorite
8
Tianeptine “Gas Station Heroin” Products: Public Health Concern or Niche Substance Use?
Favorite
97
Timeouts May Reduce Unnecessary Child Welfare Reports for Substance Exposed Newborns
Favorite
117
Treating Opioid Use Disorder: Perspective of FQHC Clinicians in Los Angeles
Favorite
38
Treatment History among Patients with Recurrent Opioid Overdoses: A Multicenter Study
Favorite
100
Trends in United States Adolescent and Young Adult Overdose Fatalities, 1999-2023
Favorite
V
90
Variation in Toxicology Testing for Substance Exposure In Pregnancy in Michigan Hospitals
Favorite
94
Vascular Changes in the Placentas of Opioid Exposed Pregnancies
Favorite
W
55
Who Gets Treatment? Substance Use Disorder Treatment Enrollment after Traumatic Injury
Favorite
116
Word of Mouth: The Key to Community Connections and HR Among PWUD
Favorite
X
7
Xylazine Positivity Rate Among Patients at an Urban Low-Barrier Access Clinic
Favorite
Y
137
Years of Life Lost from Stimulant-Involved Cardiovascular Mortality, 2014-2023
Favorite
125
Yikes! Methadone To Buprenorphine Transition During Pregnancy, In Jail, Via Telephone
Favorite
